Partner support booster for staying engaged in care
Part of Digestive system, Infections, Mental health clinical trials.
This study tests a booster session of a partner navigation program that helps people who inject drugs stay engaged in healthcare after completing hepatitis C treatment. You and your injecting partner would receive extra support to keep you both healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a history of injecting drugs.
- You finished hepatitis C treatment within the last 3 months.
- You can bring a main injecting partner to join the study with you.
- You and your partner can speak English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a telehealth program that provides support for people who inject drugs, focusing on preventing HIV and improving care for hepatitis C. It is designed specifically for people living in rural areas of the Deep South and offers a phone or video-based program that is trauma-informed and builds resilience.
This study tests a team-based approach — a pharmacist, doctor, and patient navigator working together — to help people living in permanent supportive housing get hepatitis C care. If you have hepatitis C and live in DESC housing, the study will check how well this team helps you through treatment over 2 years.
This trial is focused on people who are currently getting treatment for substance use disorder. It aims to test community partnership approaches that reduce barriers and improve support during recovery.
This project studies how to improve offering and completing HIV (and hepatitis C) tests in opioid treatment programs. It may help increase timely follow-up and linkage to care when results are positive.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This study tests a program to help men who use stimulants and are at risk for HIV reduce drug use and prevent HIV infection. Participants may get access to PrEP, a daily pill that prevents HIV, and support to lower their risk.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.